Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.432 USD | -0.63% | -5.50% | -49.92% |
05-21 | Palisade Bio, Inc. Announces Presentation of Positive Preclinical Data from PALI-2108 | CI |
05-13 | Palisade Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.92% | 4.18M | |
+47.39% | 56.61B | |
-7.52% | 39.62B | |
+35.54% | 39.25B | |
-6.90% | 28.28B | |
+10.67% | 26.44B | |
-16.38% | 20.12B | |
+29.11% | 12.51B | |
+30.13% | 12.48B | |
+0.23% | 12.2B |
- Stock Market
- Equities
- SNCA Stock
- News Palisade Bio, Inc.
- Seneca Biopharma, Inc. Announces Management Changes